MSN Group is the fastest-growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine APIs and five finished dosage facilities established across Hyderabad, USA, and Myanmar.
The group has an integrated R&D center for both API and formulation under one roof, dedicated to the research and development of pharmaceuticals to make them more accessible. With a core focus on speed and consistency in delivery, MSN has achieved the following:
More than 650 national and international patents
Product portfolio featuring over 350 + APIs
250+ Formulations, covering over 35 major therapies
Won the trust of more than 40,000,000 customers across 65 countries globally
Innovation and speed form the crux of our business strategy. Backed by a dedicated and experienced team of over 11,000 the organizational environment at MSN integrates multiple disciplines and functions by effective implementation of goals and objectives through technology, coupled with Integrity, Imagination, and Innovation.
Proactive marketing, robust IP strategy, innovative R&D expertise, dynamic SCM, Insight-driven IT and World-class facilities are our ingredients to success.
In a short span of 17 years, we achieved a record growth of 100% from USD 22 million in 2005 to USD 500 million in 2019. Outstanding workforce, cutting-edge science, state-of-the-art technology, and knowledge-intensive initiatives – our work involves creating innovative solutions for tomorrow’s healthcare requirements.